Hugel Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Hugel Inc
Access all reports
Hugel Inc is a South Korea-based biopharmaceutical company specializing in aesthetic and therapeutic medical products. The company develops, manufactures, and markets botulinum toxin products, dermal fillers, and other medical devices used in cosmetic procedures and treatments. Hugel also provides related services for aesthetic clinics and healthcare providers. Its operations include research and development, regulatory compliance, and international distribution, serving both domestic and overseas markets. The company is headquartered in Gangwon-do, South Korea, and its shares are listed on the KRX.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
A145020
Country
🇰🇷 South Korea